Status:
NOT_YET_RECRUITING
RADA16 for Aquablation Day Case
Lead Sponsor:
NYU Langone Health
Conditions:
Hematuria
Benign Prostatic Hyperplasia
Eligibility:
MALE
Phase:
PHASE2
Brief Summary
This is a pilot proof of concept single-arm study using PuraStat following Aquablation procedure to assess reduction of hematuria to allow for same day discharge. The primary objective is to assess h...
Eligibility Criteria
Inclusion
- • Any man undergoing Aquablation for LUTS due to BPH
Exclusion
- • Unwilling to sign consent
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06948331
Start Date
May 1 2025
End Date
September 1 2025
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016